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, whose axons survived for as as a model to examine the possible involvement of long as weeks after transection (Lunn et al., 1989; Glass the ubiquitin proteasome system (UPS). Inhibiting UPS et al., 1993), suggests that Wallerian degeneration inactivity by both pharmacological and genetic means
volves an active and regulated autodestruction proprofoundly delays axon degeneration both in vitro and gram. The ubiquitin-proteasome system (UPS) has been in vivo. In addition, we found that the fragmentation implicated as a common mechanism for selective proof microtubules is the earliest detectable change tein degradation in a variety of biological processes, in axons undergoing Wallerian degeneration, which such as axonal pathfinding (Campbell and Holt, 2001 ) among other degenerative events, can be delayed by and synapse formation (DiAntonio et al., 2001). In addiproteasome inhibitors. Interestingly, similar to trantion, an intragenic deletion in the gene encoding ubiquisected axons, degeneration of axons from nerve tin carboxy-terminal hydrolase has recently been found growth factor (NGF)-deprived sympathetic neurons to account for the axon degeneration phenotype of the could also be suppressed by proteasome inhibitors.
gracile axonal dystrophy (gad) mouse (Saigoh et al., Our findings suggest a possibility that inhibiting UPS 1999). Also, the slow Wallerian degeneration phenotype activity may serve to retard axon degeneration in in the Wld s mice has been attributed to the overexprespathological conditions. sion of a fusion protein that consists of the amino-terminal 70 amino acids of UFD2, an E4 protein involved in polyubiquitination, and the nicotinamide mononucleoIntroduction tide adenylyltransferase (Nmnat) , thus leaving it unclear whether there is contribution from to separation of the neuron from its targets, resulting in loss of neuronal function. In the past, much effort has UPS to the phenotype of Wld s mice. In this study, we provide both pharmacological and genetic evidence that been focused on understanding the nature of neuronal cell death in these diseases (Yuan and Yankner, 2000) .
UPS inhibition can profoundly delay Wallerian degeneration, possibly by stabilizing microtubule skeletons at the However, strategies designed to prevent neuronal cell death have resulted in only limited success in preventing early stages of Wallerian degeneration. or delaying neurodegeneration. One possibility is that neuronal cell death occurs too late in these diseases, Results so that it may not be an efficient target for therapy. Thus, interfering with the process of axon degeneration may Inhibiting the UPS Delays Wallerian Degeneration Wallerian degeneration in most transected mammalian nerve fibers is a complex sequence that entails degrada- tion of the axon, changes in the ensheathing and glial 
Crushed Optic Nerves In Vivo
As it is known that these inhibitors are able to quickly UBP2, but not control HSV, showed a significantly slower rate of degeneration ( Figures 1E and 1F ). However, the protective effects of UBP2 overexpression were also observed in other types of cultured neurons, were less robust than those of the proteasome inhibisuch as chicken dorsal root ganglion neurons and retinal tors, presumably due to the low expression levels of ganglion cells (data not shown). UBP2 ( Figure 1F) . Thus, the proteasome inhibitors were We next attempted to examine whether UPS is inused for the rest of the study. volved in axotomy-triggered Wallerian degeneration by Consistent with previous studies (Finn et al., 2000), using specific pharmacological inhibitors. It is known addition of ALLN (50 M), an inhibitor of calcium-depenthat for UPS to degrade a specific substrate protein, the dent proteases calpains, did not affect the development sequential action of three enzymes, including a ubiquitin of the axonal beading appearance but slightly delayed activating enzyme (E1), a ubiquitin conjugating enzyme the disintegration of transected axons into debris (Fig-(E2) , and a ubiquitin ligase (E3), are required to covaures 1A and 1B). These results together suggest that lently link ubiquitin to the substrate. Polyubiquitinated UPS and calpains may act on different stages of Walproteins are then targeted for degradation by the 26S lerian degeneration. Interestingly, application of the calproteasome, which is composed of two 19S proteasome cium chelator EGTA (2 mM) resulted in a much stronger regulatory particles and a 20S core. Substrate ubiquitiprotective effect on Wallerian degeneration than ALLN nation may also be reversed by ubiquitin proteases (re-( Figure 1A ) and other calpain inhibitors (data not shown 3A-3C ) and the cleavage of neurofilaments ( Figures 3D and 3E, data not shown) . Howrity of different subcellular organelles in the transected axons by both immunocytochemistry and membrane ever, ALLN only delayed neurofilament degradation (Figure 3E) , not the fragmentation of microtubules ( Figure  labeling (Figure 2) . Plasma membrane staining with both a lipophilic dye DiI (Figure 2A) (data not shown) in transected optic nerves. However, To provide additional biochemical evidence for such since the effect of drugs presoaked in gelfoams is likely an axotomy-elicited microtubule destabilization in tranto decrease over time, we could not determine the maxisected axons at early stages of Wallerian degeneration, mum extent to which these proteasome inhibitors could we separated monomeric/dimeric (soluble, S) and polyslow down Wallerian degeneration in vivo. Nevertheless, merized (pellet, P) tubulins from transected axons and these results together suggest that inhibiting UPS activmeasured the depolymerization ratio (S/[S ϩ P]) at differity is able to delay Wallerian degeneration both in vitro ent time points. As shown in Figure 3C 
